Real-world effectiveness and safety of nirmatrelvir-ritonavir (Paxlovid)-treated for COVID-19 patients with onset of more than 5 days: a retrospective cohort study

Overview of attention for article published in Frontiers in Pharmacology, August 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 24 X posts from 22 X users, with an upper bound of 39,635 followers.

RT @atranscendedman: A study in Guangzhou, China, with 248 COVID-19 patients found that Paxlovid is effective and safe when given within 10…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 20 additional X posts.